Tecport Optics Signs Exclusive Licensing Agreement With Axon Optics
June 15, 2012, Orlando, Florida and Salt Lake City, Utah, Tecport Optics Inc., today announced it has signed an Exclusive Licensing, Distribution and Intellectual Property Rights Agreement with Axon Optics LLC, a spin-off from the University of Utah.
The University of Utah has registered the existing proprietary property, which specifically includes United States provisional patent application no. 61/433,344 and PCT patent application no. PCT/US12/21500, characterized as “Process to Reduce Light Sensitivity in Individuals including Migraine Headaches”.
Bradley Katz, MD, PhD, CEO of Axon said; “This is an excellent time to introduce prescription or non-prescription eyewear for the relief of migraine headaches for consumers who are light sensitive. Our goal with this eyewear is to reduce the need for prescription and over-the-counter headache remedies. More than 30 million Americans suffer from light sensitivity and abnormal intolerance to light with multiple associations such as migraines, traumatic brain injury and blepharospasm. Half of sufferers seeking a migraine cure take a prescription medication, accounting for $2B in migraine prescription drugs sales that may result in side effects. We are very pleased to be collaborating with Tecport to commercialize these prescription and non-prescription lenses worldwide.”
Dr. Nabil El Hag, Vice Chairman of Tecport said; “We are very pleased to be working with Axon and the University of Utah on this technology. Clinical trails are in the 2nd stage and Axon is in the process of applying for FDA acceptance. This application of the Axon technology in conjunction with Tecport’s revolutionary Cold Plasma (“Polaris”)
Founded in 1997, Tecport designs, manufactures, sell and services state-of-the-
Axon Optics was born after a neuro-ophthalmologist, an optics researcher, and a marketing professional got together during the summer of 2010 to help people with migraine and light sensitivity. Using the latest research performed at the Moran Eye Center at the University of Utah, the first line of products based upon a therapeutic tint was launched June 2011. Research is underway at the Moran Eye Center to develop improved preventative migraine coatings for ophthalmic applications. http://www.axonoptics.com/
Dr. Nabil El-Hag, Vice Chairman, Tecport Optics
Tel: +1 914-420-5957
Chris Farnworth, Managing Director, Special Projects, Tecport Optics
Tel: +1 778-960-0551
Bradley Katz, M.D., Ph.D., CEO, Axon Optics
Tel: +1 801-230-4851
Page Updated Last on: Jun 20, 2012